177 related articles for article (PubMed ID: 2685680)
21. Ovarian tumors in Malawi -- a histopathological study.
Lucas SB; Vella EJ
J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):97-101. PubMed ID: 12340193
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
23. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
[TBL] [Abstract][Full Text] [Related]
24. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature.
Comerci JT; Licciardi F; Bergh PA; Gregori C; Breen JL
Obstet Gynecol; 1994 Jul; 84(1):22-8. PubMed ID: 8008317
[TBL] [Abstract][Full Text] [Related]
25. Steroid production in different parts of malignant and benign ovarian tumors in vitro.
Ridderheim M; Mählck CG; Selstam G; Stendahl U; Bäckström T
Cancer Res; 1993 May; 53(10 Suppl):2309-12. PubMed ID: 8485717
[TBL] [Abstract][Full Text] [Related]
26. Different features of the histopathological subtypes of ovarian tumors in pre- and postmenopausal women.
Jung EJ; Eom HM; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
Menopause; 2017 Sep; 24(9):1028-1032. PubMed ID: 28832426
[TBL] [Abstract][Full Text] [Related]
27. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
28. [Frequency of recurrence and repeated development of ovarian tumors after conservative operations].
Utkin IuK
Vopr Onkol; 1981; 27(3):29-32. PubMed ID: 7222519
[TBL] [Abstract][Full Text] [Related]
29. Ovarian tumours: a study of 282 cases.
Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
[TBL] [Abstract][Full Text] [Related]
30. Noncontraceptive estrogen use and the occurrence of ovarian cancer.
Weiss NS; Lyon JL; Krishnamurthy S; Dietert SE; Liff JM; Daling JR
J Natl Cancer Inst; 1982 Jan; 68(1):95-8. PubMed ID: 6948131
[TBL] [Abstract][Full Text] [Related]
31. [Histological classification in 10 288 cases of ovarian malignant tumors in China].
Shi Y; Ye D; Lu W; Zhao C; Xu J; Chen L
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):97-100. PubMed ID: 11953074
[TBL] [Abstract][Full Text] [Related]
32. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.
Dictor M
Obstet Gynecol; 1985 May; 65(5):720-4. PubMed ID: 2984621
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
34. An update on the diagnosis and treatment of common malignant ovarian tumors.
Gallup DG
J Med Assoc Ga; 1997 Sep; 86(3):181-5. PubMed ID: 9293169
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
37. Functioning ovarian tumors in postmenopausal women.
Rome RM; Fortune DW; Quinn MA; Brown JB
Obstet Gynecol; 1981 Jun; 57(6):705-10. PubMed ID: 7231823
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of benign and malignant tumor of the ovary].
Dias MF; Pereira HS; Sousa LA; Torgal IR; De Oliveira CF
Acta Med Port; 1997 Oct; 10(10):653-7. PubMed ID: 9477588
[TBL] [Abstract][Full Text] [Related]
39. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
40. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
Prayson RA; Hart WR; Petras RE
Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
